| The challenge of drug resistance in pancreatic ductal adenocarcinoma: a current overview F Quiñonero, C Mesas, K Doello, L Cabeza, G Perazzoli, C Jimenez-Luna, ... Cancer biology & medicine 16 (4), 688, 2019 | 96 | 2019 |
| Nanomedicine to overcome multidrug resistance mechanisms in colon and pancreatic cancer: recent progress R Ortíz, F Quiñonero, B García-Pinel, M Fuel, C Mesas, L Cabeza, ... Cancers 13 (9), 2058, 2021 | 29 | 2021 |
| Antioxidant and antiproliferative potential of ethanolic extracts from Moringa oleifera, Tropaeolum tuberosum and Annona cherimola in colorrectal cancer cells M Fuel, C Mesas, R Martínez, R Ortiz, F Quinonero, J Prados, JM Porres, ... Biomedicine & Pharmacotherapy 143, 112248, 2021 | 23 | 2021 |
| Synthetic circular miR-21 sponge as tool for lung cancer treatment AR Rama, F Quiñonero, C Mesas, C Melguizo, J Prados International journal of molecular sciences 23 (6), 2963, 2022 | 12 | 2022 |
| In vivo antitumor activity of Euphorbia lathyris ethanol extract in colon cancer models C Mesas, R Martínez, K Doello, R Ortiz, M López-Jurado, F Bermúdez, ... Biomedicine & Pharmacotherapy 149, 112883, 2022 | 11 | 2022 |
| The antitumor activity of sodium selenite alone and in combination with gemcitabine in pancreatic cancer: An in vitro and in vivo study K Doello, C Mesas, F Quiñonero, G Perazzoli, L Cabeza, J Prados, ... Cancers 13 (13), 3169, 2021 | 10 | 2021 |
| Novel microRNA sponges to specifically modulate gene expression in colon cancer cells AR Rama, G Perazzoli, L Cabeza, C Mesas, F Quinonero, B Garcia-Pinel, ... nucleic acid therapeutics 30 (5), 325-334, 2020 | 10 | 2020 |
| PARP1 inhibition by Olaparib reduces the lethality of pancreatic cancer cells and increases their sensitivity to Gemcitabine F Quinonero, C Mesas, JA Munoz-Gamez, C Jimenez-Luna, G Perazzoli, ... Biomedicine & Pharmacotherapy 155, 113669, 2022 | 8 | 2022 |
| Identification of PARP-1 in cancer stem cells of gastrointestinal cancers: A preliminary study F Quinonero, A Cepero, D Urbano, JA Munoz-Gamez, ... Journal of Biosciences 46, 1-11, 2021 | 6 | 2021 |
| Nanomedicine and Hyperthermia for the Treatment of Gastrointestinal Cancer: A Systematic Review L Gago, F Quiñonero, G Perazzoli, C Melguizo, J Prados, R Ortiz, ... Pharmaceutics 15 (7), 1958, 2023 | 5 | 2023 |
| Cancer Stem Cells in Sarcomas: In Vitro Isolation and Role as Prognostic Markers: A Systematic Review MA Chico, C Mesas, K Doello, F Quiñonero, G Perazzoli, R Ortiz, J Prados, ... Cancers 15 (9), 2449, 2023 | 5 | 2023 |
| Circular Sponge against miR-21 Enhances the Antitumor Activity of Doxorubicin against Breast Cancer Cells AR Rama, P Lara, C Mesas, F Quiñonero, C Vélez, C Melguizo, J Prados International Journal of Molecular Sciences 23 (23), 14803, 2022 | 5 | 2022 |
| Nanomedicine in pancreatic cancer: a new hope for treatment P Redruello, G Perazzoli, A Cepero, F Quinonero, C Mesas, K Doello, ... Current Drug Targets 21 (15), 1580-1592, 2020 | 5 | 2020 |
| Vegetal-Derived Bioactive Compounds as Multidrug Resistance Modulators in Colorectal Cancer F Quiñonero, C Mesas, M Peña, L Cabeza, G Perazzoli, C Melguizo, ... Applied Sciences 13 (4), 2667, 2023 | 4 | 2023 |
| Active Biomolecules from Vegetable Extracts with Antitumoral Activity against Pancreas Cancer: A Systematic Review (2011–2021) C Mesas, F Quiñonero, K Doello, JL Revueltas, G Perazzoli, L Cabeza, ... Life 12 (11), 1765, 2022 | 4 | 2022 |
| In vitro efficacy of extracts and isolated bioactive compounds from ascomycota fungi in the treatment of colorectal cancer: A systematic review C Luque, A Cepero, G Perazzoli, C Mesas, F Quiñonero, L Cabeza, ... Pharmaceuticals 16 (1), 22, 2022 | 3 | 2022 |
| Antibody-Functionalized Nanoformulations for Targeted Therapy of Colorectal Cancer: A Systematic Review A Cepero, C Luque, L Cabeza, G Perazzoli, F Quiñonero, C Mesas, ... International Journal of Nanomedicine 17, 5065, 2022 | 3 | 2022 |
| Antioxidant and Chemopreventive Activity of Protein Hydrolysates from Raw and Germinated Flour of Legumes with Commercial Interest in Colorectal Cancer M Fuel, C Mesas, R Martínez, R Ortiz, F Quiñonero, F Bermúdez, ... Antioxidants 11 (12), 2421, 2022 | 2 | 2022 |
| Antitumor Effect of Traditional Drugs for Neurological Disorders: Preliminary Studies in Neural Tumor Cell Lines K Doello, C Mesas, F Quiñonero, AR Rama, C Vélez, G Perazzoli, R Ortiz Neurotoxicity Research 40 (6), 1645-1652, 2022 | 2 | 2022 |
| 34P Molecular markers of response to different chemotherapeutic agents in RAS/BRAF mutated colon cancer cell lines K Doello, C Mesas, L Cabeza, MJ Gandara, F Quiñonero, R Ortiz Annals of Oncology 31, S254-S255, 2020 | 2 | 2020 |
Cristina Mesas HernándezUniversidad de Granada在 ugr.es 的电子邮件经过验证
